~~<i id='1314D6AAA5'><strike id='1314D6AAA5'><tt id='1314D6AAA5'><pre id='1314D6AAA5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：Wikipedia 2025-09-29 01:46:20 - browse：5

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Vaccine advisory panel ACIP left half staffed by HHS

Wikipedia

leisure time

hotspot

entertainment

focus

Illustration:STAT;Source:EliLilly/APACaliforniabiotechdevelopingacombinationtherapywiththeobesitydru

WSS

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Robert F. Kennedy is pitching centrism on health, even on abortion

Global cancer cases to surge 77% by 2050, WHO report says

Robert F. Kennedy is pitching centrism on health, even on abortion

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

hotspot

knowledge

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Adopting new red light myopia treatments may be short

Sports medicine is finally prioritizing gender equality

Senators start work on Medicare physician payment reform

Apple is now the first public company to be valued at $3 trillion

The dental labor crisis is a moment of opportunity

Duchenne breakthrough therapy leaves behind pioneering families

Why CTE doesn’t keep Americans from enjoying the Super Bowl

State Dept. review finds Biden bears some blame for Afghanistan failures

Key House Republican on health care plans exit from Congress

leisure time

Surgery pushed Ben Carson to fame

Senators start work on Medicare physician payment reform

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

'Revelatory' study finds a smoking impact that remains after quitting

Gene therapy for Afghan refugees’ infant will be fully covered

Adopting new red light myopia treatments may be short

hotspot

entertainment

entertainment

focus